David A. Fraser

2.6k total citations
101 papers, 1.9k citations indexed

About

David A. Fraser is a scholar working on Epidemiology, Physiology and Ecology. According to data from OpenAlex, David A. Fraser has authored 101 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 11 papers in Physiology and 9 papers in Ecology. Recurrent topics in David A. Fraser's work include Liver Disease Diagnosis and Treatment (13 papers), Diet and metabolism studies (8 papers) and Older Adults Driving Studies (6 papers). David A. Fraser is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Diet and metabolism studies (8 papers) and Older Adults Driving Studies (6 papers). David A. Fraser collaborates with scholars based in United States, United Kingdom and Canada. David A. Fraser's co-authors include J. Thöen, Jens Kjeldsen‐Kragh, Robert L. Harris, Øystein Førre, Janne E. Reseland, Stephen M. Rappaport, A.F. Fraser, Eric J. Reardon, E.R. Chavez and Stephane A. Roy and has published in prestigious journals such as Journal of the American Statistical Association, Gastroenterology and PLoS ONE.

In The Last Decade

David A. Fraser

94 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Fraser United States 24 305 217 199 190 146 101 1.9k
Hiroshi Yamakawa Japan 27 271 0.9× 84 0.4× 160 0.8× 58 0.3× 239 1.6× 271 2.6k
Mikael Andersson Sweden 30 49 0.2× 101 0.5× 64 0.3× 266 1.4× 239 1.6× 123 2.5k
Marialva Tereza Ferreira de Araújo Brazil 10 153 0.5× 328 1.5× 121 0.6× 230 1.2× 679 4.7× 20 3.3k
Meimei Zhang China 33 139 0.5× 267 1.2× 84 0.4× 172 0.9× 929 6.4× 263 4.2k
Takashi Iizuka Japan 34 359 1.2× 410 1.9× 303 1.5× 116 0.6× 1.3k 8.6× 243 3.9k
Maria Goretti Queiroz Brazil 6 153 0.5× 328 1.5× 115 0.6× 133 0.7× 648 4.4× 23 3.1k
Beatriz Helena Baldez Vasconcelos Brazil 7 153 0.5× 329 1.5× 117 0.6× 182 1.0× 677 4.6× 15 3.2k
Toshio Saito Japan 29 47 0.2× 277 1.3× 158 0.8× 157 0.8× 790 5.4× 226 3.3k
Arnaldo Jorge Martins Filho Brazil 10 154 0.5× 329 1.5× 119 0.6× 171 0.9× 685 4.7× 29 3.3k
Jorge Rodrigues de Sousa Brazil 15 153 0.5× 328 1.5× 145 0.7× 308 1.6× 749 5.1× 50 3.6k

Countries citing papers authored by David A. Fraser

Since Specialization
Citations

This map shows the geographic impact of David A. Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Fraser more than expected).

Fields of papers citing papers by David A. Fraser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Fraser. The network helps show where David A. Fraser may publish in the future.

Co-authorship network of co-authors of David A. Fraser

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Fraser. A scholar is included among the top collaborators of David A. Fraser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Fraser. David A. Fraser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harrison, Stephen A., Naim Alkhouri, Grisell Ortiz‐Lasanta, et al.. (2025). A phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASH. Journal of Hepatology. 83(2). 293–303. 4 indexed citations
2.
Fligor, Scott C., Savas T. Tsikis, Amy Pan, et al.. (2025). A medium-chain fatty acid analogue prevents endotoxin liver injury in a murine model. Scientific Reports. 15(1). 13645–13645.
3.
Fligor, Scott C., Savas T. Tsikis, Amy Pan, et al.. (2023). A Medium-Chain Fatty Acid Analogue Prevents Intestinal Failure–Associated Liver Disease in Preterm Yorkshire Piglets. Gastroenterology. 165(3). 733–745.e9. 9 indexed citations
4.
Fraser, David A., Xiaoyu Wang, Jenny Lund, et al.. (2021). A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH. Journal of Hepatology. 76(4). 800–811. 30 indexed citations
5.
Stokman, Geurt, Anita M. van den Hoek, Elsbet Pieterman, et al.. (2020). Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative. Liver International. 40(11). 2860–2876. 15 indexed citations
6.
Fraser, David A. & Hélène Massam. (2016). A Mixed Prinmal-Dual Bases Algorithm for Regression under Inequality Constraints. Application to Concave regression. Scandinavian Journal of Statistics. 16(1). 65–74. 8 indexed citations
7.
Fraser, David A., Nina P. Hessvik, Nataša Nikolić, et al.. (2011). Benfotiamine increases glucose oxidation and downregulates NADPH oxidase 4 expression in cultured human myotubes exposed to both normal and high glucose concentrations. Genes & Nutrition. 7(3). 459–469. 19 indexed citations
8.
Fraser, David A., et al.. (2005). GIS in groundwater and soil salinity modelling. RMIT Research Repository (RMIT University Library). 1 indexed citations
9.
Tanner, Philip, et al.. (2005). Developments in thermionic energy converters. IEE Proceedings - Science Measurement and Technology. 152(1). 1–6. 5 indexed citations
10.
Whitfield, Paul H., David A. Fraser, & Stewart Cohen. (2003). Climate Change Impacts on Water in Georgia Basin/Puget Sound — Special Issue. Canadian Water Resources Journal / Revue canadienne des ressources hydriques. 28(4). 523–529. 7 indexed citations
11.
Fraser, David A., Bruno G. Loos, A.J. van Winkelhoff, et al.. (2003). Polymorphisms in an interferon‐γ receptor‐1 gene marker and susceptibility to periodontitis*. Acta Odontologica Scandinavica. 61(5). 297–302. 17 indexed citations
13.
Fraser, David A.. (1999). Successful Middle and High School Tech Ed Programs.. ˜The œtechnology teacher. 58(6). 15–18.
14.
Fraser, David A., J. Thöen, Arild C. Rustan, Øystein Førre, & Jens Kjeldsen‐Kragh. (1999). Changes in plasma free fatty acid concentrations in rheumatoid arthritis patients during fasting and their effects upon T-lymphocyte proliferation. Lara D. Veeken. 38(10). 948–952. 39 indexed citations
15.
Fraser, David A., J. Thöen, Janne E. Reseland, Øystein Førre, & Jens Kjeldsen‐Kragh. (1999). Decreased CD4+ Lymphocyte Activation and Increased Interleukin-4 Production in Peripheral Blood of Rheumatoid Arthritis Patients After Acute Starvation. Clinical Rheumatology. 18(5). 394–401. 114 indexed citations
16.
Warnes, Anthony & David A. Fraser. (1993). Car Driving as a Social Skill. Gerontology & Geriatrics Education. 13(1-2). 103–127. 3 indexed citations
17.
Fraser, David A.. (1989). Re: Corporate influence on threshold limit values. American Journal of Industrial Medicine. 15(2). 235–236. 2 indexed citations
18.
Fraser, David A.. (1985). Mammals, birds, and butterflies at sodium sources in northern Ontario forests. The Canadian Field-Naturalist. 99(3). 365–367. 8 indexed citations
19.
Fraser, David A.. (1966). The Deposition of Unipolar Charged Particles in the Lungs of Animals. Archives of Environmental Health An International Journal. 13(2). 152–157. 20 indexed citations
20.
Fraser, David A., et al.. (1963). The Assessment of the Total Toxicant Exposure of Man. American Industrial Hygiene Association Journal. 24(4). 417–422. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026